If you held Schwab U.S. Dividend Equity ETF (NYSEARCA:SCHD) in a taxable brokerage account in 2024, you got an ugly surprise in the mail the following January: a 1099 showing distributions almost triple the normal quarterly amount. The fund’s index reshuffled, forced sales, and passed the tax bill straight through to you. In a Roth IRA, that would not have been a problem. In a taxable account, it was money the marketing never mentioned.
What You’re Actually Paying
SCHD’s headline expense ratio is famously low, but the real story is tax friction from index reconstitution. On June 26, 2024, SCHD paid $0.8241 per share. The next quarter it paid $0.7545 per share on September 25, 2024. Compare that to the surrounding pattern of $0.5965 to $0.6647 per share across 2023, and you can see the anomaly. Those elevated payouts followed the March 2024 reconstitution of the Dow Jones U.S. Dividend 100 Index, which triggered turnover inside the fund.
Consider what that means for an individual investor. Someone holding roughly 125 shares, equal to about a $10,000 position in mid-2024, received distributions of $0.8241 and $0.7545 per share in consecutive quarters. In a taxable account, any non-qualified portion of those distributions would create an immediate tax liability, while the same income could compound tax-free inside a Roth IRA. Assuming a combined federal and state tax rate of 25% on the taxable portion, even a relatively small annual tax drag can add up over a 20-year holding period. A large reconstitution-related distribution simply makes that ongoing tax cost more visible.
The Part the Factsheet Doesn’t Highlight
SCHD is marketed as a stable, quality-tilted dividend index. The mechanics tell a slightly different story. The top 10 holdings total approximately 47.2% of net assets, led by QUALCOMM at 6.74%, Texas Instruments at 5.90%, and UnitedHealth Group at 5.09%. That is a concentrated bet for a fund holding 150+ positions and $94.9 billion in assets as of May 31, 2026.
The concentration is not the only wrinkle. Energy exposure sits near 12% across Chevron, ConocoPhillips, EOG, Devon, ONEOK, and SLB. Healthcare hovers near 18%. Every March, the Dow Jones U.S. Dividend 100 Index rescreens holdings on cash-flow-to-debt, ROE, yield, and dividend growth. As a result, names drop out, new names come in, and the fund realizes gains selling appreciated positions. Those gains flow through as distributions whether you wanted the cash or not.
The Cheaper Mirror
The obvious peer is Vanguard High Dividend Yield ETF (NYSEARCA:VYM), which tracks a broader universe of roughly 400 dividend payers. Fees are comparable, but the exposure profile is wider, and reconstitution turnover is lower. Recent returns show the trade-off clearly. Over the past five years, SCHD returned 58.01% while VYM returned 77.77%. Year-to-date in 2026, SCHD is up 26.66% versus VYM at 17.12%, so the recent bounce has cut the other way. Over a decade, SCHD’s 235.23% return has beaten VYM’s 207.84%. The takeaway: the quality screen and the annual reconstitution are real design choices that come with real costs.
What This Means for You
SCHD is cheap on fees but expensive to hold in the wrong account. Before your next contribution, ask yourself a simple question: is this ETF sitting in a Roth where reconstitution distributions are ignored, or is it sitting in a taxable account where every March index rebalance can hand you a surprise payout you never asked for? The gap between the two answers is where the hidden cost lives.
Contact [email protected] for any questions or corrections.
Top Gaining Stocks
Top Losing Stocks